PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26036303-8	2015	Combined treatment of NSCLC cells with sulforaphane plus another HSP90 inhibitor (17-AAG) enhanced the inhibition of EGFR-related signaling both in vitro and in vivo.	sulforaphane	39-51	N-methylpurine DNA glycosylase	Homo sapiens	85-88	
21875325-3	2011	MTS assay demonstrated that sulforaphane sensitized pancreatic cancer cells to 17-AAG in vitro.	sulforaphane	28-40	N-methylpurine DNA glycosylase	Homo sapiens	82-85	
21875325-8	2011	Our data suggest that sulforaphane potentiates the efficacy of 17-AAG against pancreatic cancer through enhanced abrogation of Hsp90 function.	sulforaphane	22-34	N-methylpurine DNA glycosylase	Homo sapiens	66-69